We are live on ! Find out more
NKGN

NKGen Biotech, Inc. Common Stock

Delisted

NKGN was delisted on the 4th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
CSS
26
Cubist Systematic Strategies
Connecticut
$1.63M -$63.3K -6,530 -4%
ACM
27
Atalaya Capital Management
New York
$1.46M
CH
28
CVI Holdings
Delaware
$1.46M
JP Morgan Chase
29
JP Morgan Chase
New York
$975K +$895K +92,320 +1,121%
GF
30
Gabelli Funds
New York
$974K
SC
31
Sculptor Capital
New York
$971K
OCM
32
Oaktree Capital Management
California
$970K
GCIA
33
Gabelli & Co Investment Advisers
New York
$836K
TI
34
Telemetry Investments
New York
$578K +$57.2K +5,900 +11%
Marshall Wace
35
Marshall Wace
United Kingdom
$523K
SSA
36
Schonfeld Strategic Advisors
New York
$510K +$24.2K +2,500 +5%
Walleye Capital
37
Walleye Capital
New York
$431K
Walleye Trading
38
Walleye Trading
New York
$349K
HighTower Advisors
39
HighTower Advisors
Illinois
$316K -$3.88K -400 -1%
MF
40
Magnetar Financial
Illinois
$172K +$172K +17,700 New
AA
41
AQR Arbitrage
Connecticut
$126K
CIM
42
Corbyn Investment Management
Maryland
$110K +$110K +11,320 New
SG
43
StoneX Group
New York
$97K +$96.9K +10,000 New
AA
44
Ancora Advisors
Ohio
$10K +$9.69K +1,000 New
HIH
45
HRS Investment Holdings
New York
-$2.47M -255,000 Closed
NRCM
46
Northern Right Capital Management
Connecticut
-$1.45M -150,000 Closed
VCIM
47
Velan Capital Investment Management
Georgia
-$836K -86,506 Closed
EAM
48
Exos Asset Management
New York
-$678K -70,000 Closed